应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ZTS Zoetis Inc.
盘后交易 05-12 17:06:27 EDT
76.94
+0.27
+0.35%
盘后
77.11
+0.17
+0.22%
17:01 EDT
最高
78.67
最低
75.11
成交量
1,810万
今开
77.65
昨收
76.67
日振幅
4.64%
总市值
322.55亿
流通市值
322.55亿
总股本
4.19亿
成交额
13.90亿
换手率
4.32%
流通股本
4.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | Zoetis盘中大跌6.62%,业绩不及预期且下调全年指引引发抛售
异动解读 · 05-12 01:09
异动解读 | Zoetis盘中大跌6.62%,业绩不及预期且下调全年指引引发抛售
异动解读 | Zoetis盘中大跌7.04%,业绩不及预期且下调全年指引引发抛售
异动解读 · 05-09
异动解读 | Zoetis盘中大跌7.04%,业绩不及预期且下调全年指引引发抛售
硕腾成标普500今日最差成分股:财报“比看上去更糟”
环球市场播报 · 05-08
硕腾成标普500今日最差成分股:财报“比看上去更糟”
异动解读 | Zoetis盘中暴跌21.89%,因一季度业绩不及预期且大幅下调全年盈利指引
异动解读 · 05-08
异动解读 | Zoetis盘中暴跌21.89%,因一季度业绩不及预期且大幅下调全年盈利指引
美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%
智通财经 · 05-07
美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%
异动解读 | Zoetis盘前大跌8.74%,因下调全年业绩预期且第一季度业绩未达预期
异动解读 · 05-07
异动解读 | Zoetis盘前大跌8.74%,因下调全年业绩预期且第一季度业绩未达预期
财报前瞻|Zoetis Inc.本季度营收预计增5.26%,机构观点偏多
财报Agent · 04-30
财报前瞻|Zoetis Inc.本季度营收预计增5.26%,机构观点偏多
硕腾公司收购Neogen®动物基因组学业务,加速精准动物健康创新
美股速递 · 03-02
硕腾公司收购Neogen®动物基因组学业务,加速精准动物健康创新
异动解读 | Zoetis季度业绩及展望超预期,盘前大涨6.12%
异动解读 · 02-12
异动解读 | Zoetis季度业绩及展望超预期,盘前大涨6.12%
财报前瞻|Zoetis Inc.本季度营收预计增2.61%,机构观点偏多
财报Agent · 02-05
财报前瞻|Zoetis Inc.本季度营收预计增2.61%,机构观点偏多
别只盯着黄金白银!分析师:这一商品板块正在积累动能
智通财经 · 01-28
别只盯着黄金白银!分析师:这一商品板块正在积累动能
Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据,到期日为2029年
美股速递 · 2025-12-16
Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据,到期日为2029年
Zoetis获得加拿大卫生部批准,Portela™(Relfovetmab注射液)可缓解猫咪的骨关节炎相关疼痛
美股速递 · 2025-12-05
Zoetis获得加拿大卫生部批准,Portela™(Relfovetmab注射液)可缓解猫咪的骨关节炎相关疼痛
Zoetis获得欧洲委员会对Lenivia®(Izenivetmab)的市场许可,以减轻犬类骨关节炎相关疼痛
美股速递 · 2025-11-27
Zoetis获得欧洲委员会对Lenivia®(Izenivetmab)的市场许可,以减轻犬类骨关节炎相关疼痛
硕腾2024财年实现净利润24.86亿美元,同比增加6.06%
市场透视 · 2025-02-17
硕腾2024财年实现净利润24.86亿美元,同比增加6.06%
动保巨头年报公布!硕腾2024年盈利约198亿元,默沙东动保营收约430亿元
新牧网 · 2025-02-16
动保巨头年报公布!硕腾2024年盈利约198亿元,默沙东动保营收约430亿元
硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元
市场透视 · 2025-02-15
硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元
巴克莱:维持Zoetis(ZTS.US)评级,由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。
金融界 · 2025-02-15
巴克莱:维持Zoetis(ZTS.US)评级,由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。
硕腾发布2024年财报:宠物板块营收大增13%,中国市场迎来转折
宠物行业白皮书 · 2025-02-14
硕腾发布2024年财报:宠物板块营收大增13%,中国市场迎来转折
硕腾2024年财报:犬猫业务营收近60亿美元,增长13%
宠业家 · 2025-02-14
硕腾2024年财报:犬猫业务营收近60亿美元,增长13%
加载更多
公司概况
公司名称:
Zoetis Inc.
所属市场:
NYSE
上市日期:
--
主营业务:
硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业,专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。
发行价格:
--
{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":76.94,"timestamp":1778616000000,"preClose":76.67,"halted":0,"volume":18098085,"hourTrading":{"tag":"盘后","latestPrice":77.11,"preClose":76.94,"latestTime":"17:01 EDT","volume":1734947,"amount":133712937.82251,"timestamp":1778619718301,"change":0.17,"changeRate":0.00221,"amplitude":0.010231},"delay":0,"changeRate":0.0035215860179991653,"floatShares":419228118,"shares":419228118,"eps":6.106906,"marketStatus":"盘后交易","change":0.27,"latestTime":"05-12 17:06:27 EDT","open":77.65,"high":78.67,"low":75.11,"amount":1390374340.29315,"amplitude":0.046433,"askPrice":77.2,"askSize":1,"bidPrice":76.8,"bidSize":7,"shortable":3,"etf":0,"ttmEps":6.106906,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778630400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":76.67,"dividendRate":0.026384,"preHourTrading":{"tag":"盘前","latestPrice":77.66,"preClose":76.67,"latestTime":"09:29 EDT","volume":265703,"amount":20381703.817285,"timestamp":1778592599999,"change":0.99,"changeRate":0.012912,"amplitude":0.013825},"postHourTrading":{"tag":"盘后","latestPrice":77.11,"preClose":76.94,"latestTime":"17:01 EDT","volume":1734947,"amount":133712937.82251,"timestamp":1778619718301,"change":0.17,"changeRate":0.00221,"amplitude":0.010231},"volumeRatio":1.267701,"optionData":{"bulkOrders":[{"symbol":"ZTS","call":true,"expireDate":1784260800000,"strike":"85.0","timestamp":1778598731440,"price":2.3,"volume":3000,"amount":690000,"type":"-"}]},"impliedVol":0.3179,"impliedVolPercentile":0.5498},"requestUrl":"/m/hq/s/ZTS","defaultTab":"news","newsList":[{"id":"1180452131","title":"异动解读 | Zoetis盘中大跌6.62%,业绩不及预期且下调全年指引引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1180452131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180452131?lang=zh_cn&edition=full","pubTime":"2026-05-12 01:09","pubTimestamp":1778519348,"startTime":"0","endTime":"0","summary":"动物保健巨头Zoetis Inc. 今日盘中股价大幅下挫6.62%,延续了近期的弱势表现。消息面上,公司此前公布的第一季度业绩表现不佳,调整后每股收益为1.53美元,低于市场预期的1.61美元;营收为22.6亿美元,同样不及预期的23.1亿美元。公司管理层指出,宠物主对价格敏感度提高导致兽医就诊次数减少,美国市场收入因此下降8%,其中伴侣动物产品销售额下降11%。消费疲软对公司的核心业务形成了实质性冲击,持续压制了市场信心,引发了投资者的抛售。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198917647","title":"异动解读 | Zoetis盘中大跌7.04%,业绩不及预期且下调全年指引引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1198917647","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198917647?lang=zh_cn&edition=full","pubTime":"2026-05-09 02:22","pubTimestamp":1778264552,"startTime":"0","endTime":"0","summary":"Zoetis Inc. (ZTS) 今日盘中大跌7.04%,延续了近期股价的弱势表现。消息面上,该公司此前公布的第一季度调整后每股收益为1.53美元,低于市场预期的1.62美元;营收为23亿美元,同比增长3%,但仍不及预期。同时,公司将全财年调整后每股收益指引下调至6.85-7.00美元,全年营收指引修订为96.8亿至99.6亿美元,指引中点均低于分析师预期。公司管理层指出,第一季度经营环境比预期更具挑战,宠物主价格敏感度提高导致兽医就诊减少,美国市场收入下降8%至11亿美元,其中伴侣动物产品销售额下降11%,反映出消费疲软对核心业务的实质性冲击,这引发了市场的持续担忧和抛售压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633173744","title":"硕腾成标普500今日最差成分股:财报“比看上去更糟”","url":"https://stock-news.laohu8.com/highlight/detail?id=2633173744","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633173744?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:30","pubTimestamp":1778182200,"startTime":"0","endTime":"0","summary":"动物保健巨头硕腾周四股价暴跌逾20%,创下七年新低,成为标普500指数中表现最差的成分股。尽管财报数据已经令人失望,但多位分析师指出,实际情况比看上去更糟。 其次,美国核心宠物业务严重恶化。美国业务营收下降8%至11亿美元,其中伴侣动物产品销售额更骤降11%,主要因宠物主价格敏感度提高、兽医就诊减少。该股年初至今已累计下跌约29%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-08/doc-inhxckat7932903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ITOT","RSPU","NOBL","VEU","HIBS","SCHB","SPYG","SVIX","SDS","IVW","YSPY","VVIX","SFY","VTI","SPYI","SVOL","IJR","BK4550","BK4504","GSLC","IJH","VBK","SPMO","DBSC","OEF","TSPY","SPHQ","XLG","HIBL","VXZ","RSP","SPLV","ETFT","SPYQ","SPXL","BK4588","RSPN","XDTE","ALLW","VIXmain","GPIX","BK4585","SPYM","SPUS","SPYV","SH","OEX","ZTS","VIXM","SPGP","SPYD","VTV","SVXY","SPXS","VV","UPRO","SPYB",".SPX","BK4559","VXMmain","IVE","SPUU","JEPI","BK4581","SCHX","VYLD","SPXU","SSO","TVIXF","SPHD","SPYU","XYLD","SPDN","IVV","RSPA","VXX","MESmain","VIXY","USMV","BK4534","UVXY","MOAT","BMAY","ACWI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153119915","title":"异动解读 | Zoetis盘中暴跌21.89%,因一季度业绩不及预期且大幅下调全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1153119915","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153119915?lang=zh_cn&edition=full","pubTime":"2026-05-08 00:03","pubTimestamp":1778169823,"startTime":"0","endTime":"0","summary":"动物保健巨头Zoetis Inc.今日盘中股价大跌21.89%,引发了市场的广泛关注。消息面上,公司同时公布了不及预期的第一季度财报并下调了全年业绩指引,双重利空打击了投资者信心。具体来看,公司第一季度调整后每股收益为1.53美元,低于市场预期的1.61美元;第一季度营收为22.6亿美元,亦不及分析师预期的23.1亿美元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633129536","title":"美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633129536","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633129536?lang=zh_cn&edition=full","pubTime":"2026-05-07 23:00","pubTimestamp":1778166008,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周四,Zoetis(ZTS.US)早盘暴跌超20%,创阶段新低,现报88.05美元。消息面上,5月7日,该公司公布的第一季度调整后每股收益为1.53美元,低于市场预期的1.62美元;营收为23亿美元,增长3%,但低于部分市场预期。该公司将2026财年调整后每股收益指引下调至6.85-7.00美元,并将全年营收指引修订为96.8亿至99.6亿美元,其指引中点均低于分析师预期。公司首席执行官表示,第一季度经营环境比预期更具挑战,宠物主价格敏感度提高导致兽医就诊减少,美国市场收入因此下降8%至11亿美元,其中伴侣动物产品销售额下降11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2271345857.HKD","LU0385154629.USD","GB00BDT5M118.USD","LU2111349929.HKD","LU1059921491.USD","LU0345774631.USD","LU0079474960.USD","LU0158827948.USD","LU2089283258.USD","LU0471298777.SGD","LU2023251221.USD","BK4585","LU1941712348.USD","LU1721429741.USD","LU1236620834.HKD","LU1721429402.USD","IE00B19Z9505.USD","LU0289739699.SGD","LU0058720904.USD","LU0158827781.USD","LU2308191902.HKD","BK4534","ZTS","LU0471298694.HKD","LU2089284900.SGD","BK4588","LU2360106947.USD","LU1236620750.USD","LU1941712264.USD","LU0107464264.USD","BK4007","LU0345774391.USD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159016493","title":"异动解读 | Zoetis盘前大跌8.74%,因下调全年业绩预期且第一季度业绩未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159016493","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159016493?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:29","pubTimestamp":1778153385,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.(ZTS)今日盘前股价大跌8.74%,引发了市场关注。消息面上,公司同时宣布下调全年业绩预期,并将第一季度业绩未达分析师预期的消息公之于众。具体而言,公司将全年每股盈利预期从原先的7.00-7.10美元下调至6.85-7.00美元。此外,公司报告的第一季度调整后每股收益为1.53美元,低于分析师预期的1.61美元;第一季度营收为22.6亿美元,也低于分析师预期的23.1亿美元。业绩预期的下调和实际业绩的疲软,直接影响了投资者对公司短期盈利能力和增长前景的信心,从而导致股价在盘前交易时段承压大幅下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123843324","title":"财报前瞻|Zoetis Inc.本季度营收预计增5.26%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1123843324","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123843324?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:47","pubTimestamp":1777510038,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年05月07日盘前发布财报,市场关注营收与每股收益的同比增长以及核心产品线的延续性表现。市场一致预期本季度Zoetis Inc.营收为23.05亿美元,同比增长5.26%;调整后每股收益为1.62美元,同比增长15.90%;息税前利润为9.18亿美元,同比增长9.44%;目前未有对本季度毛利率与净利率的明确一致预测,故不予展示。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|Zoetis Inc.本季度营收预计增5.26%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162582301","title":"硕腾公司收购Neogen®动物基因组学业务,加速精准动物健康创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1162582301","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162582301?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:11","pubTimestamp":1772453469,"startTime":"0","endTime":"0","summary":"硕腾公司宣布将收购Neogen®的动物基因组学业务,此举将显著推动其在精准动物健康领域的创新进程。此次收购标志着硕腾在动物保健解决方案方面的战略布局进一步深化,旨在通过基因组学技术提升动物健康管理的精确性和效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","LU1236620750.USD","LU2023251221.USD","LU2211817866.USD","LU1236620834.HKD","BK4198","BK4534","LU1721429741.USD","LU2360106947.USD","BK4588","LU0158827948.USD","IE00B19Z9505.USD","LU0385154629.USD","LU0471298694.HKD","LU2089284900.SGD","NEOG","LU0345774391.USD","LU0079474960.USD","LU0107464264.USD","LU0289739699.SGD","LU0158827781.USD","LU0471298777.SGD","LU2028103732.USD","LU2308191902.HKD","ZTS","LU2089283258.USD","LU1941712264.USD","LU1721429402.USD","LU2271345857.HKD","BK4007","LU1941712348.USD","BK4585","LU2111349929.HKD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133797891","title":"异动解读 | Zoetis季度业绩及展望超预期,盘前大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133797891","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133797891?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:37","pubTimestamp":1770899834,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc. (ZTS) 今日盘前股价大幅上涨6.12%,表现强劲。消息面上,该公司公布的第四季度业绩及2026年财务指引均超出市场预期。具体来看,Zoetis第四季度调整后每股利润为1.48美元,高于市场预期的1.40美元。同时,公司预计2026年调整后每股收益将在7.00美元至7.10美元之间,其中间值高于分析师普遍预期的6.80美元;预计2026年营收将在98.25亿美元至100.25亿美元之间,其中间值也高于市场预期的99.14亿美元。这些乐观的业绩数据和未来展望显著提振了投资者信心,成为推动股价在盘前交易时段大幅走高的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124112870","title":"财报前瞻|Zoetis Inc.本季度营收预计增2.61%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1124112870","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124112870?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:14","pubTimestamp":1770257650,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年02月12日发布最新季度财报,市场预期其营收与每股收益将温和增长,盈利质量与费用节奏成为关注焦点。从近期机构研报与观点追踪看,市场对Zoetis Inc.的看法偏多,占比较高的一方认为本季度将延续稳健增长轨迹。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|Zoetis Inc.本季度营收预计增2.61%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606755165","title":"别只盯着黄金白银!分析师:这一商品板块正在积累动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2606755165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606755165?lang=zh_cn&edition=full","pubTime":"2026-01-28 07:27","pubTimestamp":1769556434,"startTime":"0","endTime":"0","summary":"在黄金、白银等硬商品行情持续吸引市场目光之际,软商品板块正悄悄积累动能,逐步走进“舞台”中央。化肥与基础材料板块方面,$CF工业$控股年初至今涨幅已超过18%,并录得四周连涨,为去年以来最长连胜周期。相较之下,同业$美国美盛$年内表现基本持平,凸显CF的相对强势。防御型食品板块方面,$美国达尔令国际$过去三个月累计上涨约23%,五周连涨,周线50周均线多年后首次拐头向上。","market":"us","thumbnail":"https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8466d39a9e33250f4b2bce0eef42d3d7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2fa34c06b40980242a48e390e7e61d16","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398257.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DAR","MOO","CF","BK4588","MOS","ELAN","ADM","DE","BK4585","BG","NTR","ZTS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1194652354","title":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据,到期日为2029年","url":"https://stock-news.laohu8.com/highlight/detail?id=1194652354","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194652354?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:20","pubTimestamp":1765866012,"startTime":"0","endTime":"0","summary":"Zoetis Inc. - 定价发行17.5亿美元的0.25%可转换高级票据,到期日为2029年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","ZTS","LU0079474960.USD","LU0158827948.USD","LU2089284900.SGD","LU0345774391.USD","LU1721429402.USD","LU1721429741.USD","BK4007","LU0289739699.SGD","LU0107464264.USD","LU0385154629.USD","LU2028103732.USD","LU2360106947.USD","BK4585","LU0058720904.USD","LU2308191902.HKD","LU0345774631.USD","LU2089283258.USD","LU2111349929.HKD","IE00B19Z9505.USD","LU1941712264.USD","LU1941712348.USD","LU0471298694.HKD","LU2023251221.USD","BK4534","BK4588","LU0471298777.SGD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199092124","title":"Zoetis获得加拿大卫生部批准,Portela™(Relfovetmab注射液)可缓解猫咪的骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1199092124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199092124?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941417,"startTime":"0","endTime":"0","summary":"Zoetis获得加拿大卫生部的批准,Portela™(Relfovetmab注射液)可用于缓解猫咪骨关节炎所致的疼痛。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0107464264.USD","LU2308191902.HKD","LU0289739699.SGD","LU0345774631.USD","LU1941712348.USD","LU0385154629.USD","LU1721429402.USD","LU0079474960.USD","LU2028103732.USD","LU2271345857.HKD","IE00B19Z9505.USD","LU0345774391.USD","LU2089284900.SGD","LU2023251221.USD","BK4588","ZTS","LU0471298777.SGD","LU0058720904.USD","BK4534","LU0158827781.USD","LU2360106947.USD","LU2089283258.USD","LU0471298694.HKD","BK4585","BK4007","LU1721429741.USD","LU0158827948.USD","LU2111349929.HKD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137813317","title":"Zoetis获得欧洲委员会对Lenivia®(Izenivetmab)的市场许可,以减轻犬类骨关节炎相关疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1137813317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137813317?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:16","pubTimestamp":1764191777,"startTime":"0","endTime":"0","summary":"Zoetis获得欧洲委员会对Lenivia®(Izenivetmab)的市场许可,以减轻犬类骨关节炎相关疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298777.SGD","LU2271345857.HKD","LU0058720904.USD","LU0385154629.USD","LU1941712348.USD","LU2028103732.USD","LU0289739699.SGD","LU1941712264.USD","BK4585","ZTS","LU2089283258.USD","LU0345774631.USD","BK4534","BK4007","LU0158827781.USD","BK4588","LU0107464264.USD","LU2089284900.SGD","LU2023251221.USD","LU2360106947.USD","IE00B19Z9505.USD","LU0158827948.USD","LU0345774391.USD","LU2111349929.HKD","LU0079474960.USD","LU0471298694.HKD","LU2308191902.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512046953","title":"硕腾2024财年实现净利润24.86亿美元,同比增加6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512046953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512046953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721669,"startTime":"0","endTime":"0","summary":"2月17日,硕腾公布财报,公告显示公司2024财年净利润为24.86亿美元,同比增加6.06%;其中营业收入为92.56亿美元,同比增加8.33%,每股基本收益为5.47美元。从资产负债表来看,硕腾总负债94.67亿美元,其中短期债务14.01亿美元,资产负债比为1.51,流动比率为1.76。机构评级:截至2025年2月17日,当前有15家机构对硕腾目标价做出预测,其中目标均价为214.47美元,其中最低目标价为180.00美元,最高目标价为244.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512596924","title":"动保巨头年报公布!硕腾2024年盈利约198亿元,默沙东动保营收约430亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512596924","media":"新牧网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512596924?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:43","pubTimestamp":1739702626,"startTime":"0","endTime":"0","summary":"另外,近日默沙东公布2024年财报,2024年默沙东总营收641.68亿美元,同比增长7%;2024年来自动物保健部门的营收为59亿美元,同比增长4%。2024 年第四季度净利润为5.81亿美元,摊薄每股收益为1.29美元,分别较报告期增长11%和13%。2024全年净利润为25亿美元,摊薄每股收益为5.47美元,分别较报告基础增长6%和8%。2024年,默沙东总营收641.68亿美元,同比增长7%。展望2025年,默沙东预计全球销售额将在641亿美元至656亿美元之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216184521a247e74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511571617","title":"硕腾盘中异动 临近收盘快速跳水5.02%报156.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511571617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511571617?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:50","pubTimestamp":1739566218,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时50分,硕腾股票出现波动,股价急速跳水5.02%。截至发稿,该股报156.65美元/股,成交量641.473万股,换手率1.43%,振幅4.74%。最近的财报数据显示,该股实现营业收入92.56亿美元,净利润24.86亿美元,每股收益5.47美元,毛利63.96亿美元,市盈率28.67倍。硕腾股票所在的制药行业中,整体跌幅为1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021504501996236d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0079474960.USD","LU2089284900.SGD","LU0158827948.USD","LU2023251221.USD","ZTS","BK4588","LU0471298694.HKD","BK4534","LU2111349929.HKD","LU2028103732.USD","LU0345774631.USD","LU0471298777.SGD","LU0158827781.USD","LU2308191902.HKD","LU1941712264.USD","LU2089283258.USD","LU0345774391.USD","LU0385154629.USD","LU1941712348.USD","LU2271345857.HKD","LU0289739699.SGD","BK4585","PTPI","LU0058720904.USD","BK4007","LU2360106947.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692036","title":"巴克莱:维持Zoetis(ZTS.US)评级,由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692036?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:13","pubTimestamp":1739549632,"startTime":"0","endTime":"0","summary":"巴克莱:维持Zoetis(ZTS.US)评级,由增持调整至增持评级, 目标价由242.00美元调整至244.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15001348179109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511693259","title":"硕腾发布2024年财报:宠物板块营收大增13%,中国市场迎来转折","url":"https://stock-news.laohu8.com/highlight/detail?id=2511693259","media":"宠物行业白皮书","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511693259?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:30","pubTimestamp":1739529054,"startTime":"0","endTime":"0","summary":"白皮书团队讯,2月13日,硕腾正式发布了其2024年财报:全年营收93亿美元,同比增长8%,净利润25亿美元;第四季度营收23亿美元,同比增长5%,净利润5.81亿美元。这一变化也表现在了业绩上,实际上,自2023Q1季度开始,硕腾在国内市场的营收已经连续7个季度同比下滑了。但受前三季度业绩拖累,2024年全年,硕腾中国市场累计营收2.70亿美元,同比下降约16%。附:硕腾2024年业绩演示报告End《2025年中国宠物行业白皮书》正式发布行业资料包","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214215135abcefc81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS","YINN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511694829","title":"硕腾2024年财报:犬猫业务营收近60亿美元,增长13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694829","media":"宠业家","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694829?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:30","pubTimestamp":1739525444,"startTime":"0","endTime":"0","summary":"2024全年净利润为25亿美元,摊薄每股收益为5.47美元,分别较报告基础增长6%和8%。其中,硕腾2024年第四季度营收为23亿美元,较2023年第四季度增长5%。2024 年第四季度净利润为5.81亿美元,摊薄每股收益为1.29美元,分别较报告期增长11%和13%。第四季度伴侣动物产品的营收为15.70亿美元,同比增长8%,犬猫业务线营收14.77亿美元,同比增长9%。分区域来看,硕腾美国市场2024年营收为50.74亿美元,同比增速高达11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231351a2460af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231351a2460af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":-0.3196},{"period":"1month","weight":-0.3495},{"period":"3month","weight":-0.4016},{"period":"6month","weight":-0.3677},{"period":"1year","weight":-0.5186},{"period":"ytd","weight":-0.3906}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业,专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.014971},{"month":2,"riseRate":0.615385,"avgChangeRate":0.01803},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.019618},{"month":4,"riseRate":0.5,"avgChangeRate":0.012455},{"month":5,"riseRate":0.642857,"avgChangeRate":0.001275},{"month":6,"riseRate":0.692308,"avgChangeRate":0.013528},{"month":7,"riseRate":0.846154,"avgChangeRate":0.031992},{"month":8,"riseRate":0.769231,"avgChangeRate":0.012395},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.008448},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}